TG Therapeutics Inc vs Victoria's Secret & Co — how do they compare? TG Therapeutics Inc trades at $54 (market cap $8.26B), while Victoria's Secret & Co trades at $87.09 (market cap $6.95B). The key difference: TG Therapeutics Inc is the larger of the two by market cap, and Victoria's Secret & Co is trading nearer its 52-week high, TG Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| TGTX | VSXY | |
|---|---|---|
Market Cap | $8.26B | $6.95B |
Sector | Health | Consumer Cyclical |
52-Week High | $59.06 | $88.50 |
52-Week Low | $26.39 | $18.72 |
Enterprise Value | $8.50B | $9.59B |
Trailing returns across standard periods
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →Victoria's Secret & Co is a specialty retailer of lingerie, pajamas, and beauty products with prestige fragrances and body care. It serves customers at its Lingerie and Beauty stores around the globe and online enabling them to shop the brand anywhere and anytime.
Read more on VSXY →